BMRN logo

BioMarin Pharmaceutical Inc. (BMRN) Cash From Operations

Annual CFO:

$572.84M+$413.58M(+259.69%)
December 31, 2024

Summary

  • As of today, BMRN annual cash from operations is $572.84 million, with the most recent change of +$413.58 million (+259.69%) on December 31, 2024.
  • During the last 3 years, BMRN annual cash from operations has risen by +$268.31 million (+88.10%).
  • BMRN annual cash from operations is now at all-time high.

Performance

BMRN Cash From Operations Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherBMRNcash flow metrics

Quarterly CFO:

$185.27M+$10.88M(+6.24%)
June 30, 2025

Summary

  • As of today, BMRN quarterly cash from operations is $185.27 million, with the most recent change of +$10.88 million (+6.24%) on June 30, 2025.
  • Over the past year, BMRN quarterly cash from operations has increased by +$66.51 million (+56.00%).
  • BMRN quarterly cash from operations is now -16.35% below its all-time high of $221.48 million, reached on September 30, 2024.

Performance

BMRN Quarterly Cash From Operations Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherBMRNcash flow metrics

TTM CFO:

$766.77M+$66.51M(+9.50%)
June 30, 2025

Summary

  • As of today, BMRN TTM cash from operations is $766.77 million, with the most recent change of +$66.51 million (+9.50%) on June 30, 2025.
  • Over the past year, BMRN TTM cash from operations has increased by +$437.91 million (+133.16%).
  • BMRN TTM cash from operations is now at all-time high.

Performance

BMRN TTM Cash From Operations Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherBMRNcash flow metrics

Cash From Operations Formula

CFO = Net Income + Non Cash Expenses + Changes In Working Capital

BMRN Cash From Operations Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1Y1 Year+259.7%+56.0%+133.2%
3Y3 Years+88.1%+229.5%+544.2%
5Y5 Years+1086.9%+568.0%+391.2%

BMRN Cash From Operations Highs & Lows

PeriodPeriodAnnual vs HighAnnual vs HighAnnual vs LowAnnual vs LowQuarter. vs HighQuarter. vs HighQuarter. vs LowQuarter. vs LowTTM vs HighTTM vs HighTTM vs LowTTM vs Low
3Y3-Yearat high+259.7%-16.4%+350.6%at high+453.4%
5Y5-Yearat high+1086.9%-16.4%+350.6%at high+798.2%
All-TimeAll-Timeat high+351.4%-16.4%+208.1%at high+359.2%

BMRN Cash From Operations History

DateAnnualQuarterlyTTM
Jun 2025
-
$185.27M(+6.2%)
$766.77M(+9.5%)
Mar 2025
-
$174.39M(-6.1%)
$700.26M(+22.2%)
Dec 2024
$572.84M(+259.7%)
$185.63M(-16.2%)
$572.84M(+38.1%)
Sep 2024
-
$221.48M(+86.5%)
$414.70M(+26.1%)
Jun 2024
-
$118.76M(+152.8%)
$328.86M(+17.4%)
Mar 2024
-
$46.97M(+70.9%)
$280.16M(+75.9%)
Dec 2023
$159.26M(-9.5%)
$27.48M(-79.7%)
$159.26M(+14.9%)
Sep 2023
-
$135.65M(+93.6%)
$138.56M(-14.1%)
Jun 2023
-
$70.06M(+194.8%)
$161.24M(+9.4%)
Mar 2023
-
-$73.93M(-1189.5%)
$147.40M(-16.2%)
Dec 2022
$175.90M(-42.2%)
$6.79M(-95.7%)
$175.90M(-2.4%)
Sep 2022
-
$158.32M(+181.6%)
$180.30M(+51.5%)
Jun 2022
-
$56.23M(+223.8%)
$119.03M(-18.2%)
Mar 2022
-
-$45.43M(-506.4%)
$145.59M(-52.2%)
Dec 2021
$304.54M(+256.7%)
$11.18M(-88.5%)
$304.54M(+8.8%)
Sep 2021
-
$97.06M(+17.2%)
$279.97M(+4.0%)
Jun 2021
-
$82.78M(-27.1%)
$269.12M(+25.7%)
Mar 2021
-
$113.51M(+948.1%)
$214.07M(+150.8%)
Dec 2020
$85.36M(+76.9%)
-$13.38M(-115.5%)
$85.36M(-45.3%)
Sep 2020
-
$86.21M(+210.8%)
$156.09M(+11.5%)
Jun 2020
-
$27.74M(+282.6%)
$140.01M(+59.2%)
Mar 2020
-
-$15.19M(-126.5%)
$87.94M(+82.2%)
Dec 2019
$48.26M(+138.8%)
$57.34M(-18.2%)
$48.26M(+19.8%)
Sep 2019
-
$70.13M(+388.1%)
$40.29M(+132.0%)
Jun 2019
-
-$24.34M(+55.6%)
$17.37M(+121.3%)
Mar 2019
-
-$54.87M(-211.1%)
$7.85M(-61.2%)
Dec 2018
$20.21M(+330.8%)
$49.37M(+4.6%)
$20.21M(+238.9%)
Sep 2018
-
$47.20M(+239.4%)
-$14.55M(+38.0%)
Jun 2018
-
-$33.86M(+20.4%)
-$23.46M(-180.4%)
Mar 2018
-
-$42.51M(-390.9%)
$29.18M(+433.2%)
Dec 2017
-$8.76M(+96.2%)
$14.61M(-61.8%)
-$8.76M(+62.9%)
Sep 2017
-
$38.29M(+103.9%)
-$23.58M(+67.4%)
Jun 2017
-
$18.78M(+123.3%)
-$72.24M(+47.2%)
Mar 2017
-
-$80.44M(>-9900.0%)
-$136.83M(+39.9%)
Dec 2016
-$227.84M(-2.7%)
-$210.00K(+98.0%)
-$227.84M(+23.0%)
Sep 2016
-
-$10.37M(+77.4%)
-$295.83M(-2.6%)
Jun 2016
-
-$45.80M(+73.3%)
-$288.31M(-12.9%)
Mar 2016
-
-$171.45M(-151.4%)
-$255.33M(-15.1%)
Dec 2015
-$221.85M(-198.9%)
-$68.20M(-2293.0%)
-$221.85M(-23.0%)
Sep 2015
-
-$2.85M(+77.8%)
-$180.43M(+3.3%)
Jun 2015
-
-$12.83M(+90.7%)
-$186.61M(-0.7%)
Mar 2015
-
-$137.97M(-415.3%)
-$185.31M(-149.7%)
Dec 2014
-$74.21M(-24.4%)
-$26.78M(-196.5%)
-$74.21M(-26.4%)
Sep 2014
-
-$9.03M(+21.7%)
-$58.73M(+0.8%)
Jun 2014
-
-$11.53M(+57.1%)
-$59.19M(-8.7%)
Mar 2014
-
-$26.87M(-137.9%)
-$54.48M(+8.6%)
Dec 2013
-$59.63M(-438.7%)
-$11.30M(-19.0%)
-$59.63M(-64.0%)
Sep 2013
-
-$9.49M(-39.2%)
-$36.35M(-187.5%)
Jun 2013
-
-$6.82M(+78.7%)
-$12.65M(-74.5%)
Mar 2013
-
-$32.03M(-367.2%)
-$7.25M(-141.2%)
Dec 2012
$17.61M(-6.1%)
$11.99M(-15.7%)
$17.61M(+223.2%)
Sep 2012
-
$14.21M(+1101.0%)
$5.45M(+5634.7%)
Jun 2012
-
-$1.42M(+80.2%)
$95.00K(-99.4%)
Mar 2012
-
-$7.17M(-3997.7%)
$15.08M(-19.6%)
DateAnnualQuarterlyTTM
Dec 2011
$18.75M(+0.0%)
-$175.00K(-102.0%)
$18.75M(+496.1%)
Sep 2011
-
$8.86M(-34.7%)
$3.15M(-5.9%)
Jun 2011
-
$13.57M(+487.7%)
$3.34M(-72.1%)
Mar 2011
-
-$3.50M(+77.8%)
$12.00M(-36.0%)
Dec 2010
$18.75M(-78.6%)
-$15.78M(-274.3%)
$18.75M(-65.3%)
Sep 2010
-
$9.06M(-59.2%)
$53.99M(-27.0%)
Jun 2010
-
$22.22M(+583.7%)
$74.01M(+4.3%)
Mar 2010
-
$3.25M(-83.3%)
$70.96M(-19.1%)
Dec 2009
$87.73M(+1056.2%)
$19.47M(-33.0%)
$87.73M(+21.5%)
Sep 2009
-
$29.07M(+51.6%)
$72.23M(+60.4%)
Jun 2009
-
$19.17M(-4.2%)
$45.04M(+36.2%)
Mar 2009
-
$20.02M(+404.7%)
$33.06M(+460.4%)
Dec 2008
-$9.18M(+73.4%)
$3.97M(+110.5%)
-$9.18M(+17.2%)
Sep 2008
-
$1.89M(-73.8%)
-$11.08M(+51.2%)
Jun 2008
-
$7.19M(+132.4%)
-$22.70M(+38.0%)
Mar 2008
-
-$22.22M(-1176.6%)
-$36.59M(-6.1%)
Dec 2007
-$34.49M(+31.1%)
$2.06M(+121.2%)
-$34.49M(+27.1%)
Sep 2007
-
-$9.73M(-45.3%)
-$47.29M(+5.6%)
Jun 2007
-
-$6.70M(+66.7%)
-$50.10M(+1.4%)
Mar 2007
-
-$20.13M(-87.5%)
-$50.84M(-1.5%)
Dec 2006
-$50.09M(+20.1%)
-$10.73M(+14.5%)
-$50.09M(+13.7%)
Sep 2006
-
-$12.55M(-68.7%)
-$58.03M(+14.1%)
Jun 2006
-
-$7.44M(+61.6%)
-$67.57M(-6.1%)
Mar 2006
-
-$19.38M(-3.8%)
-$63.65M(-1.6%)
Dec 2005
-$62.68M(+3.8%)
-$18.67M(+15.4%)
-$62.68M(-17.2%)
Sep 2005
-
-$22.08M(-526.6%)
-$53.48M(-3.9%)
Jun 2005
-
-$3.52M(+80.9%)
-$51.47M(+25.9%)
Mar 2005
-
-$18.40M(-94.4%)
-$69.51M(-6.7%)
Dec 2004
-$65.14M(+12.9%)
-$9.46M(+52.9%)
-$65.14M(+26.5%)
Sep 2004
-
-$20.08M(+6.9%)
-$88.66M(+2.8%)
Jun 2004
-
-$21.56M(-53.7%)
-$91.22M(-18.4%)
Mar 2004
-
-$14.03M(+57.5%)
-$77.03M(-3.0%)
Dec 2003
-$74.80M(-39.6%)
-$32.99M(-45.7%)
-$74.80M(+1.6%)
Sep 2003
-
-$22.64M(-206.9%)
-$76.01M(-27.7%)
Jun 2003
-
-$7.38M(+37.5%)
-$59.52M(-4.3%)
Mar 2003
-
-$11.80M(+65.5%)
-$57.06M(-6.5%)
Dec 2002
-$53.59M(-132.4%)
-$34.20M(-456.0%)
-$53.59M(-113.9%)
Sep 2002
-
-$6.15M(-25.2%)
-$25.06M(-0.3%)
Jun 2002
-
-$4.91M(+41.1%)
-$24.99M(-12.4%)
Mar 2002
-
-$8.33M(-47.1%)
-$22.24M(+3.6%)
Dec 2001
-$23.07M(-78.9%)
-$5.66M(+7.0%)
-$23.07M(-13.8%)
Sep 2001
-
-$6.09M(-181.5%)
-$20.27M(-27.9%)
Jun 2001
-
-$2.16M(+76.4%)
-$15.85M(+2.2%)
Mar 2001
-
-$9.15M(-219.1%)
-$16.21M(-25.7%)
Dec 2000
-$12.90M(+0.3%)
-$2.87M(-72.4%)
-$12.90M(+2.3%)
Sep 2000
-
-$1.66M(+34.0%)
-$13.21M(+27.3%)
Jun 2000
-
-$2.52M(+56.9%)
-$18.17M(-23.7%)
Mar 2000
-
-$5.84M(-83.8%)
-$14.69M(-13.5%)
Dec 1999
-$12.94M(-60.6%)
-$3.18M(+52.0%)
-$12.94M(-32.6%)
Sep 1999
-
-$6.63M(-790.8%)
-$9.76M(-211.3%)
Jun 1999
-
$959.10K(+123.4%)
-$3.14M(+23.4%)
Mar 1999
-
-$4.09M
-$4.09M
Dec 1998
-$8.06M(-161.1%)
-
-
Dec 1997
-$3.09M
-
-

FAQ

  • What is BioMarin Pharmaceutical Inc. annual cash from operations?
  • What is the all-time high annual cash from operations for BioMarin Pharmaceutical Inc.?
  • What is BioMarin Pharmaceutical Inc. annual cash from operations year-on-year change?
  • What is BioMarin Pharmaceutical Inc. quarterly cash from operations?
  • What is the all-time high quarterly cash from operations for BioMarin Pharmaceutical Inc.?
  • What is BioMarin Pharmaceutical Inc. quarterly cash from operations year-on-year change?
  • What is BioMarin Pharmaceutical Inc. TTM cash from operations?
  • What is the all-time high TTM cash from operations for BioMarin Pharmaceutical Inc.?
  • What is BioMarin Pharmaceutical Inc. TTM cash from operations year-on-year change?

What is BioMarin Pharmaceutical Inc. annual cash from operations?

The current annual cash from operations of BMRN is $572.84M

What is the all-time high annual cash from operations for BioMarin Pharmaceutical Inc.?

BioMarin Pharmaceutical Inc. all-time high annual cash from operations is $572.84M

What is BioMarin Pharmaceutical Inc. annual cash from operations year-on-year change?

Over the past year, BMRN annual cash from operations has changed by +$413.58M (+259.69%)

What is BioMarin Pharmaceutical Inc. quarterly cash from operations?

The current quarterly cash from operations of BMRN is $185.27M

What is the all-time high quarterly cash from operations for BioMarin Pharmaceutical Inc.?

BioMarin Pharmaceutical Inc. all-time high quarterly cash from operations is $221.48M

What is BioMarin Pharmaceutical Inc. quarterly cash from operations year-on-year change?

Over the past year, BMRN quarterly cash from operations has changed by +$66.51M (+56.00%)

What is BioMarin Pharmaceutical Inc. TTM cash from operations?

The current TTM cash from operations of BMRN is $766.77M

What is the all-time high TTM cash from operations for BioMarin Pharmaceutical Inc.?

BioMarin Pharmaceutical Inc. all-time high TTM cash from operations is $766.77M

What is BioMarin Pharmaceutical Inc. TTM cash from operations year-on-year change?

Over the past year, BMRN TTM cash from operations has changed by +$437.91M (+133.16%)
On this page